Cours Propanc Biopharma Inc Other OTC
Actions
US74346N1072
Recherche biotechnologique et médicale
CA 2022 | - | CA 2023 | - | Capitalisation | 559 k 499 k |
---|---|---|---|---|---|
Résultat net 2022 | -2 M -1,79 M | Résultat net 2023 | -2 M -1,79 M | VE / CA 2022 | - |
Dette nette 2022 | 1,09 M 978 k | Dette nette 2023 | 536 k 479 k | VE / CA 2023 | - |
PER 2022 |
-0,07
x | PER 2023 |
-0,08
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 99,78% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 50 | 15/10/07 | |
Julian Kenyon
FOU | Founder | 77 | 15/10/07 |
Klaus Kutz
CTO | Chief Tech/Sci/R&D Officer | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 50 | 15/10/07 | |
Julian Kenyon
FOU | Founder | 77 | 15/10/07 |
Josef Zelinger
BRD | Director/Board Member | 74 | 23/12/20 |
Varia. 1 janv. | Capi. | |
---|---|---|
+20,17% | 127 Md | |
+24,67% | 117 Md | |
+25,44% | 27,67 Md | |
-17,74% | 20,33 Md | |
-15,17% | 16,79 Md | |
-15,21% | 15,63 Md | |
+11,91% | 14,84 Md | |
-47,10% | 14,65 Md | |
+54,50% | 14,43 Md |